Evidence map›Paper›PMID 34339055›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2021

Developmental lineage of human pluripotent stem cell-derived cardiac fibroblasts affects their functional phenotype.

Martha E Floy, Sophie E Givens, Oriane B Matthys, Taylor D Mateyka, Charles M Kerr, Alexandra B Steinberg, Ana C Silva, Jianhua Zhang, Ying Mei, Brenda M Ogle and 3 more

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Martha E FloyDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI, USA.ORCID https://orcid.org/0000-0003-1992-5911
Sophie E GivensDepartment of Biomedical Engineering, University of Minnesota, Minneapolis, MN, USA.
Oriane B MatthysUC Berkeley-UC San Francisco Graduate Program in Bioengineering, Berkley, CA, USA.ORCID https://orcid.org/0000-0002-5530-7945
Taylor D MateykaDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI, USA.
Charles M KerrMolecular Cell Biology and Pathobiology Program, Medical University of South Carolina, Charleston, SC, USA.ORCID https://orcid.org/0000-0001-8736-4795
Alexandra B SteinbergDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI, USA.
Ana C SilvaGladstone Institute of Cardiovascular Disease, Gladstone Institutes, San Francisco, CA, USA.
Jianhua ZhangDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, USA.
Ying MeiDepartment of Bioengineering, Clemson University, Clemson, SC, USA.
Brenda M OgleDepartment of Biomedical Engineering, University of Minnesota, Minneapolis, MN, USA.ORCID https://orcid.org/0000-0001-7613-7490
Todd C McDevittGladstone Institute of Cardiovascular Disease, Gladstone Institutes, San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-8905-4931
Timothy J KampDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, USA.ORCID https://orcid.org/0000-0003-2103-7876
Sean P PalecekDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI, USA.ORCID https://orcid.org/0000-0003-4917-5584
University of Wisconsin–Madison · USGladstone Institutes · USUniversity of Minnesota · USClemson University · USMedical University of South Carolina · US

Funding

TRAINING TO IMPROVE CARDIOVASCULAR THERAPIEST32HL007260 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MENICK, DONALD R. · 1985 to 2021
$11.1M
Regulating human pluripotent stem cell differentiation by colony confinementR01EB007534 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI PALECEK, SEAN P · 2007 to 2019
$4.1M
Epicardial regulation of cardiomyocyte function via modulation of extracellular signals: toward a model of human muscle pump functionR01HL160779 · NHLBI · UNIVERSITY OF MINNESOTA · PI OGLE, BRENDA M · 2022 to 2025
$1.9M
Extracellular matrix regulation of differentiation via modulation of ILK: application to 3D bioprinting of cardiac tissueR01HL137204 · NHLBI · UNIVERSITY OF MINNESOTA · PI MCALPINE, MICHAEL, OGLE, BRENDA M · 2017 to 2020
$1.7M
Nanowired human cardiac spheroids for heart repairR01HL133308 · NHLBI · CLEMSON UNIVERSITY · PI MEI, YING · 2017 to 2020
$1.5M
Improving cardiovascular disease modeling using human pluripotent stem cell-derived cardiac fibroblastsF31HL154665 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KERR, CHARLES MATTHEW · 2020 to 2022
$126k
NHLBI NIH HHS F31 HL154665NHLBI NIH HHS R01 HL133308NHLBI NIH HHS R01 HL137204NHLBI NIH HHS R01 HL160779NHLBI NIH HHS T32 HL007260NIBIB NIH HHS R01 EB007534
6 · The paper itself

Abstract

Cardiac fibroblasts (CFBs) support heart function by secreting extracellular matrix (ECM) and paracrine factors, respond to stress associated with injury and disease, and therefore are an increasingly important therapeutic target. We describe how developmental lineage of human pluripotent stem cell-derived CFBs, epicardial (EpiC-FB), and second heart field (SHF-FB) impacts transcriptional and functional properties. Both EpiC-FBs and SHF-FBs exhibited CFB transcriptional programs and improved calcium handling in human pluripotent stem cell-derived cardiac tissues. We identified differences including in composition of ECM synthesized, secretion of growth and differentiation factors, and myofibroblast activation potential, with EpiC-FBs exhibiting higher stress-induced activation potential akin to myofibroblasts and SHF-FBs demonstrating higher calcification and mineralization potential. These phenotypic differences suggest that EpiC-FBs have utility in modeling fibrotic diseases while SHF-FBs are a promising source of cells for regenerative therapies. This work directly contrasts regional and developmental specificity of CFBs and informs CFB in vitro model selection.

Indexed as

Cell DifferentiationCell LineageCells, CulturedExtracellular MatrixHumansMyocardiumMyocytes, CardiacMyofibroblastsPhenotypePluripotent Stem CellsTranscription, Geneticcardiacfibroblastpluripotent stem cell

Identifiers

PMID34339055
PMCPMC8349112
OpenAlexW3187590106

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.